Please Wait...

Alzheimer's Association International Conference (AAIC)

July 13, 2019 - 1:00am (EDT) to July 18, 2019 - 1:00am (EDT)

Bioclinica will share scientific outcomes utilizing imaging techniques in the study of Alzheimer’s disease and other dementias in several scientific posters and presentations during the AAIC Annual Conference and the AIC Preconference. To learn more, speak with Bioclinica presenters, indicated in bold.

  • Centiloid Scale in Practice: Effect of Different SUVr Reference Regions and Comparison of Centiloid Cut-Offs

                       Session Details: Poster #32590, Amyloid Imaging

                       Date: July 13, 12:30 - 2 PM

                       Authors: Kate Adamczuk, Mehul Sampat, Luc Bracoud, Maureen Runkle, Beth Gorman, Joyce Suhy, David Scott

  • Worsening Functional Connectivity within Default Mode Network Is Associated with Higher AV-1451 PET Uptake in Medial Temporal Lobe

                       Session Details: Poster #32463, Brain Networks and Connectivity

                       Date: July 13, 12:30 - 2PM

                       Authors: David Scott, Luc Bracoud, Kate Adamczuk, Joyce Suhy

  • Optimizing the Selection of Cortical Thickness Regions to Predict MCI Progression to AD Dementia – Application to ROSAS and ADNI

                       Session Details: Poster #31985, Imaging correlates of cognition and biomarkers

                       Date: July 13, 12:30 – 2 PM

                       Authors: Perrine Soret, Luc Bracoud, Laura Xuereb, Fabrice Bonneville, Joel Schaerer, David Scott, Joyce Suhy, Bruno Vellas, Anette Merdes and the Alzheimer's Disease Neuroimaging Initiative

  • Evaluation of Tau Deposition in Amyloid Positive MCI or Mild-AD Dementia Subjects from the Elenbecestat Mission AD Program Using [18F]PI-2620 PET

                       Session Details: Poster #33606, Evaluating treatments with neuroimaging

                       Date: July 13, 12:30 – 2 PM

                       Authors: Andrew Stephens, Santiago Bullich, Andre Mueller, Mathias Berndt, Susan De Santi, David Scott, Katarzyna Adamczuk, Joyce Suhy, June Kaplow, Stephen Krause, Julia Chang, Bruce Albala, Johan Luthman

  • Centiloid Scale in Practice: Effect of Different SUVr Reference Regions and Comparison of Centiloid Cut-Offs

Session Details: Oral Presentation #32276, O1-10 Neuroimaging: Amyloid Accumulation

Date: July 14, 4:15- 5:45 PM

Authors: Kate Adamczuk, Mehul Sampat, Luc Bracoud, Maureen Runkle, Beth Gorman, Joyce Suhy, David Scott

  • Worsening Functional Connectivity within Default Mode Network Is Associated with Higher AV-1451 PET Uptake in Medial Temporal Lobe

Session Details: Poster #32429, P1-09: Diagnosis and Prognosis: Neuroimaging

Date: July 14, 9:30 AM - 4:15 PM

Authors: David Scott, Luc Bracoud, Kate Adamczuk, Joyce Suhy

  • Neurofibrillary Tangle Imaging with [18F]MK-6240 in Apecs, a Phase 3 Trial in Prodromal Alzheimer’s Disease Patients

Session Details: Poster #32571, P1-01, Therapeutics: Clinical

Date: July 14, 9:30 AM - 4:15 PM

Authors: Cyrille Sur, Talakad G. Lohith, James Kost, David Scott, Katarzyna Adamczuk, Tiffini Voss, and Michael Egan

  • Defining Amyloid PET Positivity – What If the Coin Had More Than 2 Sides?

Session Details: Oral Presentation #32100, O2-03-04, Neuroimaging: Amyloid PET Positivity

Date: July 15, 2 - 3:30 PM

Authors: Kevin McRae-McKee, Chinedu T. Udeh-Momoh, Geraint Price, Sumali Bajaj, Celeste A. de Jager, David Scott, Christoforos Hadjichrysanthou, Emily McNaughton, Luc Bracoud, Frank de Wolf, Roy M. Anderson, Lefkos T. Middleton, Alzheimer’s Disease Neuroimaging Initiative

  • Optimizing the Selection of Cortical Thickness Regions to Predict MCI Progression to AD Dementia – Application to ROSAS and ADNI

Session Details: Poster #31959, P3-09, Diagnosis and Prognosis: Neuroimaging

Date: July 16, 9:30 AM - 4:15 PM

Authors: Perrine Soret, Luc Bracoud, Laura Xuereb, Fabrice Bonneville, Joel Schaerer, David Scott, Joyce Suhy, Bruno Vellas, Anette Merdes and the Alzheimer's Disease Neuroimaging Initiative

  • Verubecestat-Induced Brain Volume Loss Occurs Rapidly and Only in Amyloid-Enriched Brain Regions in EPOCH, a Phase 3 Trial in Mild-to-Moderate Alzheimer’s Disease Patients

Oral Presentation #32518, O3-10 Clinical: Human Trials - Anti-amyloid and Anti-tau

Date: July 16, 4:15 - 5:45 PM, O3-10-02

Authors: Cyrille Sur, James Kost, David Scott, Katarzyna Adamczuk, Nick C Fox, Jeffrey Cummings, Pierre Tariot, Paul Aisen, Bruno Vellas, Tiffini Voss, Yuki Mukai, David Michelson, Michael Egan

  • Evaluation of Tau Deposition in Amyloid Positive MCI or Mild-AD Dementia Subjects from the Elenbecestat Mission AD Program Using [18F]PI-2620 PET

Oral Presentation #33083: O4-12, Neuroimaging: Tau PET Imaging Relationships

Date: July 17, 4:15 - 5:45 PM, O4-12-05

Authors: Andrew Stephens, Santiago Bullich, Andre Mueller, Mathias Berndt, Susan De Santi, David Scott, Katarzyna Adamczuk, Joyce Suhy, June Kaplow, Stephen Krause, Julia Chang, Bruce Albala, Johan Luthman

Event Website

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Is Your Study Supply Chain Management Solution Increasing the Risk of Stock Out Situations? https://t.co/zGMRSwAunZ… https://t.co/4BiypLB06k
Bioclinica (14 hours ago)
Here are the five questions to ask your IRT vendor. https://t.co/JSc0RwKOyp #clinicaltrials #irt https://t.co/TbMgM8ull8
Bioclinica (Yesterday)
Over 25 years of experience, we offer world-renowned scientific expertise, regulatory leadership, and integrated te… https://t.co/owAFAqIHT7
Bioclinica (2 days ago)
Your trial needs Bioclinica experts who can see more deeply into essential imaging data. We offer expertise in… https://t.co/mNdCRkZYeI
Bioclinica (3 days ago)
Attending #AAIC19? Connect with Bioclinica #alzheimersdisease clinical trials experts or join us in a session.… https://t.co/PZtsd3IiRs
Bioclinica (5 days ago)
Monitoring change in liver disease is evolving, and our experts are leading the way. Clinical imaging can be used t… https://t.co/sQRAOhtSsI
Bioclinica (6 days ago)

Latest Blogs:

Medical Imaging of Non-Alcoholic Fatty Liver Diseases in Clinical Trials
EDC Provider Selection
Site Payments Solutions
Nonalcoholic steatohepatitis (NASH) development programs
Dr. Joby John
Transformational Trends in Investigator Site Payments
Clinical Supply Chain Success: Leveraging Technology
Blood pressure monitor
Prescription box